Innate Immunity and Toll-Like Receptors

Innate immunity is the fast, germline-encoded first line of defence that senses danger through pattern-recognition receptors such as Toll-like receptors. By detecting microbial molecules and host danger signals, these receptors trigger inflammation and shape adaptive responses — a process that, when chronically engaged by self-derived ligands, contributes to rheumatic autoimmune and autoinflammatory disease.

Definition

Innate immunity is the antigen-non-specific arm of host defence mediated by pattern-recognition receptors — including Toll-like receptors that recognise pathogen- and damage-associated molecular patterns — which initiate inflammatory and antimicrobial responses.

Scope

The topic covers the receptors and signalling of innate immune sensing, especially Toll-like receptors and the inflammasome, and how their persistent activation feeds rheumatic inflammation. It treats innate immunity as a mechanism underlying disease, not as clinical guidance.

Core questions

• What molecular patterns do Toll-like and other pattern-recognition receptors detect?
• How does innate sensing translate into inflammatory cytokine output?
• How do self-derived ligands sustain innate activation in autoimmunity?
• What is the role of the inflammasome in autoinflammatory rheumatic disease?

Key concepts

• Pattern-recognition receptors
• Pathogen-associated molecular patterns (PAMPs)
• Damage-associated molecular patterns (DAMPs)
• Toll-like receptor signalling (MyD88 pathway)
• Nucleic-acid-sensing TLRs and autoimmunity
• NLRP3 inflammasome and interleukin-1
• Autoinflammation

Mechanisms

Toll-like receptors and other pattern-recognition receptors detect conserved microbial structures (PAMPs) and host danger signals (DAMPs), then signal through adaptors such as MyD88 to activate transcription factors that drive cytokine production, as reviewed by Takeuchi & Akira (2010). Nucleic-acid-sensing Toll-like receptors are of particular interest in autoimmunity because self DNA and RNA, often delivered within immune complexes, can engage them and perpetuate inflammation. A parallel innate platform, the inflammasome — notably NLRP3 — assembles in response to danger signals and activates interleukin-1 family cytokines, a pathway central to autoinflammatory disease (Davis et al., 2011). In rheumatoid arthritis, innate sensing in the synovium feeds the cytokine networks described by McInnes & Schett (2011).

Clinical relevance

Innate immune pathways explain how chronic inflammation can arise and persist without a classic foreign antigen, underpinning the concept of autoinflammation and motivating interleukin-1-directed therapies. This entry describes the biology and its disease associations and is not a basis for individual diagnosis or treatment.

History

The discovery in the 1990s that Toll-like receptors sense microbial patterns established the molecular basis of innate immune recognition and earned later recognition in immunology. The subsequent description of the inflammasome and interleukin-1-driven autoinflammation extended innate immunity into rheumatology, providing a mechanism for diseases not explained by autoantibodies alone.

Key figures

• Shizuo Akira
• Osamu Takeuchi
• Jenny Ting
• Bruce Beutler
• Jules Hoffmann

Seminal works

• takeuchi-akira-2010
• davis-2011

Frequently asked questions

How can innate immunity drive autoimmune disease if it is not antigen-specific?

Self-derived nucleic acids and damage signals can engage pattern-recognition receptors such as nucleic-acid-sensing Toll-like receptors, sustaining inflammation even without a foreign antigen and amplifying adaptive autoimmune responses.

What is the difference between Toll-like receptors and the inflammasome?

Toll-like receptors are membrane sensors that signal to induce gene transcription of inflammatory mediators, whereas the inflammasome is an intracellular protein complex that processes and activates interleukin-1 family cytokines; both are innate sensors but act at different steps.